• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿片类药物治疗的临床意义。

Clinical Implications of Opioid Therapy.

机构信息

Department of Anesthesiology and Perioperative Medicine, Pain Management, UCLA, 1245 16th Street #225, Santa Monica, CA, 90404, USA.

Department of Anesthesiology and Perioperative Medicine, UCLA, Los Angeles, CA, USA.

出版信息

Cancer Treat Res. 2021;182:107-124. doi: 10.1007/978-3-030-81526-4_8.

DOI:10.1007/978-3-030-81526-4_8
PMID:34542879
Abstract

Although opioids are potent central acting broad-spectrum analgesics, their effectiveness is diminished by various factors pertaining to their metabolism, drug interactions, genetic issues, adverse/side effects, and potential for abuse. All these factors present potential barriers to effective analgesia requiring specific considerations in clinical practice, which include monitoring and case-based intervention.

摘要

尽管阿片类药物是有效的中枢作用广谱镇痛药,但由于其代谢、药物相互作用、遗传问题、不良反应和滥用潜力等各种因素,其有效性会降低。所有这些因素都对有效的镇痛构成了潜在的障碍,这在临床实践中需要特别考虑,包括监测和基于病例的干预。

相似文献

1
Clinical Implications of Opioid Therapy.阿片类药物治疗的临床意义。
Cancer Treat Res. 2021;182:107-124. doi: 10.1007/978-3-030-81526-4_8.
2
Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.慢性非癌性疼痛阿片类药物的合理、安全与有效处方:美国介入性疼痛医师协会(ASIPP)指南
Pain Physician. 2017 Feb;20(2S):S3-S92.
3
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).阿片类药物与老年人慢性重度疼痛的管理:一个国际专家小组的共识声明,重点关注世界卫生组织第三阶梯临床最常用的六种阿片类药物(丁丙诺啡、芬太尼、氢吗啡酮、美沙酮、吗啡、羟考酮)。
Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.
4
Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?阿片类药物相关副作用对中重度慢性非癌痛治疗不足影响的评估:曲马多,解决问题的一步?
Curr Med Res Opin. 2010 Jul;26(7):1677-84. doi: 10.1185/03007995.2010.483941.
5
Implications of opioid analgesia for medically complicated patients.阿片类镇痛药对合并症较多的患者的影响。
Drugs Aging. 2010 May;27(5):417-33. doi: 10.2165/11536540-000000000-00000.
6
Peripherally-acting opioids.外周作用的阿片类药物。
Pain Physician. 2008 Mar;11(2 Suppl):S121-32.
7
Replacement of current opioid drugs focusing on MOR-related strategies.针对 MOR 相关策略的当前阿片类药物替代。
Pharmacol Ther. 2020 Jun;210:107519. doi: 10.1016/j.pharmthera.2020.107519. Epub 2020 Mar 9.
8
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
9
The use of long-acting opioids in chronic pain management.长效阿片类药物在慢性疼痛管理中的应用。
Nurs Clin North Am. 2003 Sep;38(3):435-45. doi: 10.1016/s0029-6465(02)00094-4.
10
Opioid and adjuvant analgesics: compared and contrasted.阿片类和辅助镇痛药:比较与对比
Am J Hosp Palliat Care. 2011 Aug;28(5):378-83. doi: 10.1177/1049909111410298. Epub 2011 May 26.

本文引用的文献

1
Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era.阿片类药物流行时代晚期癌症患者的疼痛管理
Am Soc Clin Oncol Educ Book. 2019 Jan;39:24-35. doi: 10.1200/EDBK_100020. Epub 2019 May 17.
2
Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy.低剂量纳曲酮(LDN):免疫相关疾病和癌症治疗中具有广阔前景的一种治疗方法。
Int Immunopharmacol. 2018 Aug;61:178-184. doi: 10.1016/j.intimp.2018.05.020. Epub 2018 Jun 7.
3
Opioid Rotation in Cancer Pain Treatment.癌症疼痛治疗中的阿片类药物转换。
Dtsch Arztebl Int. 2018 Mar 2;115(9):135-142. doi: 10.3238/arztebl.2018.0135.
4
The Safety and Efficacy of Low-Dose Naltrexone in the Management of Chronic Pain and Inflammation in Multiple Sclerosis, Fibromyalgia, Crohn's Disease, and Other Chronic Pain Disorders.低剂量纳曲酮在多发性硬化症、纤维肌痛症、克罗恩病和其他慢性疼痛疾病的慢性疼痛和炎症管理中的安全性和疗效。
Pharmacotherapy. 2018 Mar;38(3):382-389. doi: 10.1002/phar.2086. Epub 2018 Feb 23.
5
Therapies and mechanisms of opioid withdrawal.阿片类药物戒断的治疗方法及机制。
Pain Manag. 2017 Nov;7(6):455-459. doi: 10.2217/pmt-2017-0028. Epub 2017 Nov 10.
6
CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.美国 2016 年慢性疼痛阿片类药物处方指南。
JAMA. 2016 Apr 19;315(15):1624-45. doi: 10.1001/jama.2016.1464.
7
The effectiveness of buprenorphine for treating cancer pain: an abridged Cochrane review.丁丙诺啡治疗癌痛的有效性:Cochrane系统评价摘要
BMJ Support Palliat Care. 2016 Sep;6(3):292-306. doi: 10.1136/bmjspcare-2015-000939. Epub 2015 Dec 15.
8
Perioperative Dextromethorphan as an Adjunct for Postoperative Pain: A Meta-analysis of Randomized Controlled Trials.围手术期右美沙芬作为术后疼痛辅助用药:随机对照试验的荟萃分析
Anesthesiology. 2016 Mar;124(3):696-705. doi: 10.1097/ALN.0000000000000950.
9
Strategies to prevent opioid misuse, abuse, and diversion that may also reduce the associated costs.预防阿片类药物滥用、误用和转移的策略,这些策略也可能降低相关成本。
Am Health Drug Benefits. 2011 Mar;4(2):107-14.
10
The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain.低剂量纳曲酮(LDN)作为慢性疼痛新型抗炎治疗方法的应用。
Clin Rheumatol. 2014 Apr;33(4):451-9. doi: 10.1007/s10067-014-2517-2. Epub 2014 Feb 15.